Dec. 1, 2025 — RapidAI and Amazon Web Services (AWS) have announced a strengthened working relationship to accelerate the global adoption and scalability of deep clinical AI in healthcare. The companies will focus on co-development and go-to-market alignment, bringing together AWS’s AI infrastructure and machine learning pipelines with RapidAI’s deep clinical expertise and multimodal healthcare data.

Nov. 30, 2025 – Metrasens, a provider of ferromagnetic detection systems for MRI safety, has launched Metrasens Vantage at the Radiological Society of North America (RSNA) annual conference in Chicago. The Zone IV entry control system represents a significant advancement in MRI safety, delivering the industry's earliest threat detection combined with intelligent alert management and comprehensive AI-powered data and analytics.

Nov. 26, 2025 — GE HealthCare has announced it received FDA Premarket Authorization for Pristina Recon DL, an advanced 3D mammography image reconstruction technology. Powered by deep learning, Pristina Recon DL sets a new standard in image definition and sharpness.

Nov. 28, 2025 — Mosaic Clinical Technologies, the technology and AI services division of Radiology Partners, has appointed Mike Peresie as president of Mosaic. Peresie joins Mosaic with more than two decades of experience leading high-growth innovation portfolios and scaled software, network and data businesses. 

Nov. 27, 2025— AdvaHealth Solutions is highlighting AdvaPACS, its cloud-native and AI-forward imaging platform at RSNA 2025. AdvaPACS brings together imaging workflow capabilities, including reporting, diagnostic viewing, clinician access and patient access, through a fully managed cloud-native platform that requires no local servers, no complex setup, and can be activated in under 15 minutes.

Nov.26, 2025 — Micro-X Ltd., a provider of  miniaturized X-ray technology, will launch its newly updated Rover mobile X-ray system at RSNA 2025 in Chicago, marking the international debut of the upgraded platform.

Nov. 25, 2025 —Bracco Diagnostics Inc. has announced that the U.S. Food and Drug Administration (FDA) has expanded the indication for the Bracco-branded Max 3, a Rapid Exchange and Syringeless Injector for use in magnetic resonance imaging (MRI) procedures. In addition to single-dose and multi-dose vials, the Max 3 system is now indicated for use with the newly approved VUEWAY (gadopiclenol) injection Imaging Bulk Package (IBP) in 30 mL and 50 mL formats.

Nov. 25, 2025 — OmniZare will showcase its groundbreaking Dielectric Tomography Scanner platform at RSNA 2025 in Chicago (Booth 8100). The company will demonstrate the technology's capabilities in two different demonstration units: a cranial scanner for diagnosing strokes and other potential brain injuries; and a handheld scanner for wellness applications and trauma-related injuries.

Nov. 25, 2025 – Medical imaging AI company Avicenna.AI has announced a strategic partnership with Ferrum, an AI Governance Suite supporting more than 50 industry-leading algorithms. Under the agreement, Ferrum will now commercialize Avicenna.AI’s full portfolio of imaging AI solutions across the United States.

Nov. 25, 2025 — RapidAI has announced the U.S. Food and Drug Administration (FDA) clearance of five new imaging modules: Rapid DeltaFuse, Rapid LMVO, Rapid MLS, Rapid OH and Rapid Aortic for measurement. These clearances mark a significant expansion of the Rapid Enterprise Platform, reinforcing RapidAI’s identity as the only platform purpose-built to bring deep clinical intelligence, seamless workflow integration, and secure IT infrastructure to hospitals worldwide.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now